Systematic Reviews of Patient-Reported Outcomes in Patients with Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Systematic Review or Meta-Analysis in Cancer Research".
Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 21656
In recent years, the relevance of patient-reported outcomes in cancer research, as well as in other fields of medicine, has been better recognized. In fact, the definition of the real value of a treatment for patients with cancer should necessarily include the evaluation of their subjective experience.
Unfortunately, while health-related quality of life (QoL) is universally considered to be a measure of clinical benefit, its inclusion in clinical trials and in related publications remains suboptimal. Consequently, systematic reviews and meta-analyses are rarely focused on QoL and patient-reported outcomes. However, even when the experimental treatment shows a benefit in terms of overall survival, QoL results can be helpful to define the trade-off between benefits and harms, especially if the survival benefit is modest and the potential treatment-related toxicity is not negligible. In addition, QoL analysis is even more important when the interpretation of the trial is based on a surrogate endpoint (such as progression-free survival); in this case, a patient-focused assessment is crucial to define the value of a radiologically defined result.
With the aim of improving the scientific discussion about these issues and their visibility, this Special Issue will welcome contributions in the field of systematic reviews and meta-analyses focused on patient-reported outcomes and QoL in cancer research.
Prof. Dr. Massimo Di Maio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- systematic review
- patient-reported outcomes
- clinical trials